Literature DB >> 8431205

Proteolytic inactivation of alpha 1-antitrypsin and alpha 1-antichymotrypsin by neutrophils in arthritic joints.

J J Abbink1, A M Kamp, J H Nuijens, T J Swaak, C E Hack.   

Abstract

OBJECTIVE: In vitro, activated neutrophils create a microenvironment in which proteinase inhibitors are inactivated through the coordinate action of reactive oxygen species and released elastase. We investigated whether such a mechanism may contribute to the destruction of the joint tissues in arthritis.
METHODS: We analyzed the state of alpha 1-antitrypsin (alpha 1AT) and alpha 1-antichymotrypsin (alpha 1ACT), the two major inhibitors of the neutrophilic serine proteinases, in synovial fluid (SF) from patients with inflammatory arthropathies (n = 71) and osteoarthritis (OA) (n = 11), and related the results to neutrophil activation in SF.
RESULTS: The ratio of functional to antigenic levels of alpha 1AT in SF of patients with inflammatory joint diseases was similar to that of alpha 1AT in normal plasma, whereas that of alpha 1ACT was significantly decreased. Patients with inflammatory arthropathies had significantly higher levels of inactivated alpha 1AT (i alpha 1AT) and inactivated alpha 1ACT (i alpha 1ACT) in SF (as determined with monoclonal antibodies specific for the inactivated [i.e., proteolytically inactivated and/or complexed] forms of these inhibitors) than patients with OA (P < 0.005). Inactivated alpha 1AT and i alpha 1ACT levels corresponded to 0.3-11% and 3-99%, respectively, of the total amount of these inhibitors in SF. Most of the i alpha 1AT in SF had a lower M(r) than that of native alpha 1AT. Inactivated alpha 1ACT in SF had an M(r) identical to that of nonfunctional alpha 1ACT in plasma treated with chymotrypsin. Levels of both i alpha 1AT and i alpha 1ACT correlated significantly with lactoferrin and elastase levels.
CONCLUSION: These results suggest that alpha 1AT and alpha 1ACT in arthritic joints are inactivated in part by activated neutrophils, suggesting a role for these cells in impairment of the local balance between proteinases and their inhibitors in arthritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431205     DOI: 10.1002/art.1780360206

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  Pivotal role for alpha1-antichymotrypsin in skin repair.

Authors:  Daniel C Hoffmann; Christine Textoris; Felix Oehme; Tobias Klaassen; Andreas Goppelt; Axel Römer; Burkhard Fugmann; Jeffrey M Davidson; Sabine Werner; Thomas Krieg; Sabine A Eming
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

Review 2.  Cefoperazone prevents the inactivation of alpha(1)-antitrypsin by activated neutrophils.

Authors:  F Dallegri; P Dapino; N Arduino; M Bertolotto; L Ottonello
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  The inhibitory effects of antirheumatic drugs on the activity of human leukocyte elastase and cathepsin G.

Authors:  J Steinmeyer; D A Kalbhen
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

4.  Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin.

Authors:  Yuan-Ping Han; Chunli Yan; Warren L Garner
Journal:  J Invest Dermatol       Date:  2008-04-10       Impact factor: 8.551

Review 5.  Serpins in cartilage and osteoarthritis: what do we know?

Authors:  David J Wilkinson
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.